Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Response To First-Line Treatment In Stem Cell Transplant (SCT) and Non-SCT Patients With Newly Diagnosed Multiple Myeloma Who Are Enrolled In The Connect MM Registry

Rafat Abonour, MD, Jatin J. Shah, M.D., Brian Durie, MD, Howard Terebelo, DO, Cristina J Gasparetto, MD, Jayesh Mehta, MD, Mohit Narang, MD, Sachdev P Thomas, MD, Kathleen Toomey, MD, Kristen A Sullivan, MBA, CCRA, Shankar Srinivasan, PhD, Yasir Nagarwala, MD, Robert M Rifkin, MD

Blood (2013) 122 (21): 3207.

https://doi.org/10.1182/blood.V122.21.3207.3207

Published: 2013

Journal Articles

Variation in Health-Related Quality of Life by Line of Therapy of Patients with Chronic Lymphocytic Leukemia

Neil E. Kay, MD, Christopher R. Flowers, MD, Mark Weiss, MD, Nicole Lamanna, MD, Ian W. Flinn, MD, PhD, David Grinblatt, MD, Thomas J. Kipps, MD, PhD, Mark Kozloff, Susan Lerner, MS, Jeff Sharman, MD, Ren Yu, MA, Zeba M. Khan, PhD, Thomas K. Street, RPh, Arlene S. Swern, PhD, Kristen A. Sullivan, MBA, Chris L Pashos, PhD

Blood (2012) 120 (21): 3926.

https://doi.org/10.1182/blood.V120.21.3926.3926

Published: 2012

Journal Articles

Variation in Health-Related Quality of Life by Age Among Patients with Chronic Lymphocytic Leukemia

Chris L. Pashos, PhD, Christopher R Flowers, MD, Mark Weiss, MD, Nicole Lamanna, MD, Charles M Farber, MD, PhD, Thomas J. Kipps, M.D., Ph.D, Susan Lerner, MS, BA, Neil Kay, MD, Jeff Porte Sharman, MD, David L. Grinblatt, MD, Ian W. Flinn, MD, PhD, Mark Kozloff, MD, Arlene S Swern, PhD, Zeba M. Kahn, Ph.D, Thomas K. Street, RPh, Kristen A Sullivan, MBA, Gale Harding, MA, Michael J Keating, MD

Blood (2011) 118 (21): 2085.

https://doi.org/10.1182/blood.V118.21.2085.2085

Published: 2011

Journal Articles

Association of Race with Health-Related Quality of Life (HRQOL) Among Multiple Myeloma Patients

Chris L. Pashos, PhD, Brian GM Durie, MD, Robert Rifkin, MD, Howard Terebelo, DO, Cristina Gasparetto, MD, Jayesh Mehta, MD, Kathleen Toomey, MD, Rafat Abonour, MD, Rafael Fonseca, MD, Mohit Narang, MD, Jatin J Shah, MD, Arlene S Swern, PhD, Kristen A Sullivan, MBA, Thomas K. Street, RPh, Zeba M. Khan, PhD

Blood (2011) 118 (21): 5070.

https://doi.org/10.1182/blood.V118.21.5070.5070

Published: 2011

Journal Articles

Patterns of Care for Patients with Chronic Lymphocytic Leukemia (CLL): The Connect ® CLL Disease Registry

Jeff Sharman, MD, Christopher R Flowers, MD, Mark Weiss, MD, David Grinblatt, MD, Charles Farber, MD, PhD, Neil Kay, MD, Thomas Kipps, MD, Nicole Lamanna, MD, Chris Pashos, PhD, Ian W Flinn, MD, Mark Kozloff, MD, Susan Lerner, MS, Arlene S Swern, PhD, Kristen A Sullivan, MBA, Thomas K. Street, RPh, Michael Keating, MBBS

Blood (2011) 118 (21): 2864.

https://doi.org/10.1182/blood.V118.21.2864.2864

Published: 2011

Journal Articles

Association of Changes in Transfusion Status with Changes in Health-Related Quality of Life of Real-World Patients with MDS Across Six Months of Treatment with Azacitidine

Chris L. Pashos, PhD, David L. Grinblatt, MD, Mikkael A. Sekeres, MD, MS, Rami S. Komrokji, MD, Mohit Narang, MD, Arlene S Swern, PhD, Thomas K. Street, RPh, Kristen A Sullivan, MBA, Gale Harding, MA, Zeba M. Khan, PhD

Blood (2011) 118 (21): 2796.

https://doi.org/10.1182/blood.V118.21.2796.2796

Published: 2011

Journal Articles

Variation in Health-Related Quality of Life (HRQOL) Among Multiple Myeloma Patients by Insurance Coverage

Blood (2011) 118 (21): 3150.

https://doi.org/10.1182/blood.V118.21.3150.3150

Published: 2011

Journal Articles

Variation in Health-Related Quality of Life by ECOG Performance Status and Fatigue Among Patients with Chronic Lymphocytic Leukemia

Chris L. Pashos, PhD, Christopher R Flowers, MD, Mark Weiss, MD, Nicole Lamanna, MD, Charles M Farber, MD, PhD, Thomas J. Kipps, M.D., Ph.D, Susan Lerner, MS, BA, Neil Kay, MD, Jeff Porte Sharman, MD, David L. Grinblatt, MD, Ian W. Flinn, MD, PhD, Mark Kozloff, MD, Arlene S Swern, PhD, Zeba M. Kahn, Ph.D, Thomas K. Street, RPh, Gale Harding, MA, Kristen A Sullivan, MBA, Michael J Keating, MD

Blood (2011) 118 (21): 4591.

https://doi.org/10.1182/blood.V118.21.4591.4591

Published: 2011

Journal Articles

Therapeutic Response to Azacitidine (AZA) In Patients with Secondary Myelodysplastic Syndromes (sMDS) Enrolled In the AVIDA Registry

Mikkael A. Sekeres, MD, MS, Mohit Narang, MD, Rami S. Komrokji, MD, Jaroslaw P Maciejewski, MD, PhD, FACP, Alan F. List, MD, Thomas K. Street, R.Ph, MBA, Arlene S. Swern, PhD, Kristen A. Sullivan, MBA, David L. Grinblatt, MD

Blood (2010) 116 (21): 2931.

https://doi.org/10.1182/blood.V116.21.2931.2931

Published: 2010

Journal Articles

Variation In Health-Related Quality of Life (HRQOL) by ISS Stage and ECOG Status Among Multiple Myeloma Patients.

Chris L Pashos, PhD, Brian G. M. Durie, MD, Robert M. Rifkin, MD, Jatin J Shah, BS, MD, Thomas K. Street, RPh, Kristen A. Sullivan, MBA, Zeba M. Khan, PhD

Blood (2010) 116 (21): 3828.

https://doi.org/10.1182/blood.V116.21.3828.3828

Published: 2010

Journal Articles

New US Myeloma Registry (Connect MM® – The Multiple Myeloma Disease Registry): Features of Newly Diagnosed Patients In 2010

Brian G. M. Durie, MD, Jatin J. Shah, BS, MD, Rafat Abonour, MD, Cristina Gasperetto, MD, Jayesh Mehta, MD, Chris L. Pashos, PhD, Kathleen Toomey, MD, Mohit Narang, MD, Howard Terebelo, DO, Fernando Camacho, MD, Arlene S. Swern, PhD, Thomas K. Street, RPh, Kristen A. Sullivan, MBA, Robert M. Rifkin, MD

Blood (2010) 116 (21): 5032.

https://doi.org/10.1182/blood.V116.21.5032.5032

Published: 2010

Journal Articles

A Study Comparing Dosing Regimens and Efficacy of Subcutaneous to Intravenous Azacitidine (AZA) for the Treatment of Myelodysplastic Syndromes (MDS).

Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD, David W. Donley, David L. Grinblatt, MD, Mohit Narang, MD, James M. Malone, III, MD, Rami S. Komrokji, MD, Alan F List, MD, Julie G. Baker, David A. Sweet, CMR, Kristen A. Sullivan

Blood (2009) 114 (22): 3797.

https://doi.org/10.1182/blood.V114.22.3797.3797

Published: 2009

Journal Articles

Transfusion Independence in Patients with Hematologic Disorders Receiving Azacitidine Who Are Enrolled in AVIDA, a Longitudinal Patient Registry

David L. Grinblatt, MD, Mohit Narang, MD, James M. Malone, III, MD, David A. Sweet, Tim S. Dunne, Kristen A. Sullivan

Blood (2008) 112 (11): 2683.

https://doi.org/10.1182/blood.V112.11.2683.2683

Published: 2008

Journal Articles

Treatment of Patients with Low-Risk Myelodysplastic Syndromes Receiving Azacitidine Who Are Enrolled in AVIDA, a Longitudinal Patient Registry.

David L. Grinblatt, MD, Mohit Narang, MD, James M. Malone, III, MD, David A. Sweet, Tim S. Dunne, Kristen A. Sullivan

Blood (2008) 112 (11): 1646.

https://doi.org/10.1182/blood.V112.11.1646.1646

Published: 2008

NARROW

Response To First-Line Treatment In Stem Cell Transplant (SCT) and Non-SCT Patients With Newly Diagnosed Multiple Myeloma Who Are Enrolled In The Connect MM Registry

Variation in Health-Related Quality of Life by Line of Therapy of Patients with Chronic Lymphocytic Leukemia

Variation in Health-Related Quality of Life by Age Among Patients with Chronic Lymphocytic Leukemia

Association of Race with Health-Related Quality of Life (HRQOL) Among Multiple Myeloma Patients

Patterns of Care for Patients with Chronic Lymphocytic Leukemia (CLL): The Connect ® CLL Disease Registry

Association of Changes in Transfusion Status with Changes in Health-Related Quality of Life of Real-World Patients with MDS Across Six Months of Treatment with Azacitidine

Variation in Health-Related Quality of Life (HRQOL) Among Multiple Myeloma Patients by Insurance Coverage

Variation in Health-Related Quality of Life by ECOG Performance Status and Fatigue Among Patients with Chronic Lymphocytic Leukemia

Therapeutic Response to Azacitidine (AZA) In Patients with Secondary Myelodysplastic Syndromes (sMDS) Enrolled In the AVIDA Registry

Variation In Health-Related Quality of Life (HRQOL) by ISS Stage and ECOG Status Among Multiple Myeloma Patients.

New US Myeloma Registry (Connect MM® – The Multiple Myeloma Disease Registry): Features of Newly Diagnosed Patients In 2010

A Study Comparing Dosing Regimens and Efficacy of Subcutaneous to Intravenous Azacitidine (AZA) for the Treatment of Myelodysplastic Syndromes (MDS).

Transfusion Independence in Patients with Hematologic Disorders Receiving Azacitidine Who Are Enrolled in AVIDA, a Longitudinal Patient Registry

Treatment of Patients with Low-Risk Myelodysplastic Syndromes Receiving Azacitidine Who Are Enrolled in AVIDA, a Longitudinal Patient Registry.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only